Publications and reports
Below is a list of publications that use data held by the Cancer Institute NSW.
This includes:
- NSW Cancer Registry
- NSW Clinical Cancer Registry (2008–2012)
- BreastScreen NSW
- NSW Pap Test Register
- Cancer Institute Tobacco Tracking Survey
Published date 20 March 2019
There are marked variations in non-Hodgkin lymphoma (NHL) incidence rates in populations in each world region. Improving the quality of haematological information in population-based cancer registries would facilitate international comparisons of NHL incidence.
Published date 15 March 2019
Dietary intake of nutrients involved in one-carbon metabolism and risk of gastric cancer: a prospect
Source:
Nutr Cancer. 2019;71(4):605-614
The results do not support increasing intakes of B vitamins or other nutrients involved in one-carbon metabolism to reduce gastric cancer risk in a well-nourished population.
Published date 10 March 2019
Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis a
The estimated rate of overdiagnosis of prostate cancer was in agreement with estimates using other methods. The excess lifetime risk of prostate cancer in 2012 (adjusted for changing competing mortality) was 8.2%, corresponding to 41% of prostate cancers being overdiagnosed.
Published date 01 March 2019
Strategies that reduce the uptake of smoking and encourage current smokers to quit could substantially reduce the future incidence of pancreatic cancer in Australia, particularly among men.
Published date 01 March 2019
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for gl
Widespread coverage of both human papillomavirus vaccination and cervical screening from 2020 onwards has the potential to avert up to 12·5-13·4 million cervical cancer cases by 2069.
Published date 01 March 2019
Almost three quarters of children diagnosed with one of twelve solid malignancies had localised or regional disease at diagnosis, and differences in 5-year survival by stage were greatest for osteosarcoma, neuroblastoma, and rhabdomyosarcoma.
Published date 01 March 2019
Poorer survival for patients with Ewing family tumors not on a standard treatment protocol highlights the importance of ensuring all patients receive optimal care.
Published date 25 February 2019
Alcohol consumption and current use of oral contraceptives for ≥5 years explains 18.8% of premenopausal future breast cancer burden, while overweight or obesity, current use of menopausal hormone therapy or alcohol consumption explains 24.2% of postmenopausal breast cancer burden.
Published date 25 February 2019
Stage at diagnosis for children with blood cancers in Australia: Application of the Toronto Paediatr
Stage at diagnosis was applied to population data on children with blood cancers, showing variable survival by stage for acute lymphoblastic leukemia and non-Hodgkin lymphoma, but no difference in survival by stage for acute myeloid leukemia. Almost all children with Hodgkin lymphoma survived five years.
Published date 21 February 2019
Models that include multigenerational family history, such as BOADICEA and IBIS, have better ability to predict breast cancer risk, even for women at average or below-average risk of breast cancer.
